AVALIAÇÃO DO POTENCIAL TRIPANOCIDA DE DERIVADOS TIOSSEMICARBAZONAS: UMA REVISÃO

Authors

DOI:

https://doi.org/10.47820/recima21.v2i9.658

Keywords:

Drug synthesis; Trypanocidal activity; Trypanosoma cruzi; Thiosemicarbazones.

Abstract

Neglected diseases are a group of communicable diseases that mainly affect tropical regions in developing countries. Among this group of diseases is Chagas disease, which has been classified among the six most important parasitic diseases in the world, and it is estimated that more than one billion people are at risk in countries that are considered endemic. The aim of this study is to conduct a literature review on the trypanocidal activity of thiosemicarbazone derivatives. The study is a review research that used 31 articles to highlight the scientific findings on the trypanocidal activity of the derivatives in question. Articles were included in the time estimate between 2010 - 2021 (last 12 years). The search and selection of the reference studies was performed in Scielo, Science Direct, PubMed and Google Academic databases. The literature highlights that thiosemicarbazones are considered privileged compounds with a wide scientific interest due to their diverse chemical and biological properties, such as: antitumor, antibacterial, antiviral, antiprotozoal, and anti-chagasic. The studies presented here, which demonstrate the investigations of compounds of this class and their derivatives, are an important step towards the conception of therapeutic methods against Trypanosoma cruzi. New studies are necessary to elucidate in an even more specific way the effects of these derivatives in vivo, in order to obtain an alternative pharmacological therapy for Chagas disease.

Downloads

Download data is not yet available.

Author Biographies

Daniel Lopes Araújo, Universidade Federal de Pernambuco

Universidade Federal de Pernambuco

Vinicius Santos Silva, Centro Universitário de Patos

Centro Universitário de Patos

Bruno Abilio da Silva Machado

Centro Universitário Maurício de Nassau Teresin

References

ARAÚJO, D. L.; SOUZA, M. S.; DA SILVA MACHADO, B. A.; MASCARENHAS, J. M. F.; ALVES, S. P.; DO NASCIMENTO, M. L. M.; DE OLIVEIRA, J. E. G. Clinical and symptomatological characterization regarding Chagas disease caused by the Trypanosoma cruzi parasite. Research, Society and Development, v. 10, n. 5, p. e16110514873-e16110514873, 2021.

ARRÚA, E. C.; SEREMETA, K. P.; BEDOGNI, G. R.; OKULIK, N. B.; SALOMON, C. J. Nanocarriers for effective delivery of benznidazole and nifurtimox in the treatment of Chagas disease: a review. Acta tropica, v. 198, 2019.

BOLETIM EPIDEMIOLÓGICO. Brasília: Secretaria de Vigilância em Saúde, 2015. v. 46, n. 21.

BELTRAN-HORTELANO, I.; ALCOLEA, V.; FONT, M.; PÉREZ-SILANES, S. The role of imidazole and benzimidazole heterocycles in Chagas disease: A review. European Journal of Medicinal Chemistry, 2020.

BRASIL. Situação epidemiológica. Brasília: Ministério da Saúde. [20--].

COSTA, L. B. Avaliação farmacológica de novas hidrazonas, candidatas a fármacos leishmanicida e tripanocida. 2015. Thesis (Doctoral) – Universidade Federal de Pernambuco, Recife, 2015.

DA SILVA, A. P.; DANTAS, G. M. S.; DA SILVA, P. I. F.; DE MEDEIROS, A. N. G.; JUNIOR, T. N. Doenças negligenciadas e indústria farmacêutica: o caso da Doença de Chagas. Research, Society and Development, v. 10, n. 2, p. e21110212419-e21110212419, 2021.

DA SILVA, A. A.; DA SILVA, P. I. M.; LOPES, C. D.; DE ALBUQUERQUE, S.; VALLE, M. S. Synthesis, characterization and antichagasic evaluation of thiosemicarbazones prepared from chalcones and dibenzalacetones. Journal of Molecular Structure, v. 1232, 2021.

DELGADO-MALDONADO, T.; NOGUEDA-TORRES, B.; ESPINOZA-HICKS, J. C.; VÁZQUEZ-JIMÉNEZ, L. K.; PAZ-GONZÁLEZ, A. D.; JUÁREZ-SALDÍVAR, A.; RIVERA, G. Synthesis and biological evaluation in vitro and in silico of N-propionyl-N′-benzeneacylhydrazone derivatives as cruzain inhibitors of Trypanosoma cruzi. Molecular Diversity, p. 1-12, 2020.

DE SOUZA, M. L.; JUNIOR, C. D. O. R.; FERREIRA, R. S.; ESPINOZA CHÁVEZ, R. M.; FERREIRA, S. B. W.; ANDRICOPULO, A. D. Carbamoyl Imidazoles As Potent, Reversible and Competitive Cruzain Inhibitors with in vitro and in vivo Trypanocidal. Activity: A Structure-Based Drug Design Approach, 2019.

ECHEVERRIA, L. E.; MORILLO, C. A. American trypanosomiasis (Chagas disease). Infectious Disease Clinics, v. 33, n. 1, p. 119-134, 2019.

HASSAN, M.; GHAFFARI, R.; SARDARI, S.; FARAHANI, Y. F.; MOHEBBI, S. Discovery of novel isatin-based thiosemicarbazones: synthesis, antibacterial, antifungal, and antimycobacterial screening. Research in Pharmaceutical Sciences, v. 15, n. 3, p. 281, 2020.

HEFFETER, P.; PAPE, V. F.; ENYEDY, É. A.; KEPPLER, B. K.; SZAKACS, G.; KOWOL, C. R. Anticancer thiosemicarbazones: chemical properties, interaction with iron metabolism, and resistance development. Antioxidants & redox signaling, v. 30, n. 8, p. 1062- 1082, 2019.

Downloads

Published

11/10/2021

How to Cite

Lopes Araújo, D., Eufrazino Júnior, J., Santos Silva, V. ., Franco Mendonça de Araújo , C. ., Hevellin Evangelista, T. ., Hevellin Evangelista, H. ., … Abilio da Silva Machado, B. (2021). AVALIAÇÃO DO POTENCIAL TRIPANOCIDA DE DERIVADOS TIOSSEMICARBAZONAS: UMA REVISÃO . RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218, 2(9), e29658. https://doi.org/10.47820/recima21.v2i9.658